GATM and neoplasm: This relation of AGAT expression and clinical outcome in brain tumour patients, a tumour site in which methylating/alkylating agents have some utility, may not be applicable in other malignancies, where the mechanisms of chemotherapy resistance may be independent of AGAT expression (Middleton et al, 1998).